Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01705288 · ClinicalTrials.gov registry record · Early Phase 1
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
A Early Phase 1 study, sponsored by Masonic Cancer Center, University of Minnesota.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 103
- Enrollment target
NCT01705288: Completed Early Phase 1 study, sponsored by Masonic Cancer Center, University of Minnesota.
NCT01705288 is a Early Phase 1 study that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 103 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (94% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01705288, a Early Phase 1 study, has completed, sponsored by Masonic Cancer Center, University of Minnesota.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 103 participants
- Enrollment target
Study Summary
Over 600,000 hysterectomies are performed annually in the United States. Despite increasing use of less invasive approaches, the majority of hysterectomies are still performed via traditional laparotomy, which can be associated with generally slower recovery and longer lengths of post-operative hospitalization. Rapid Recovery Protocols (RRP) seek to optimize post-surgical morbidity outcomes by returning a patient to normal physiology as quickly as possible following surgery.
Primary Outcome
Length of hospital stay for patients undergoing laparotomy on the gynecologic oncology service measured as whole days from the day of surgery until discharge
Interventions
- PROCEDURE Laparotomy
- DRUG intravenous narcotics
- DRUG standard anesthesia
- DRUG regional anesthesia
- DRUG Non-steroidal anti-inflammatory drugs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2013-01-01 |
| Est. Completion | 2016-08-24 |
| Phase | Early Phase 1 |
What the finished NCT01705288 record still lists
NCT01705288 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (94% higher).
The record links to 0 conditions, and to 5 interventions - of which Laparotomy is the first listed.
NCT01705288 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01705288 about?
NCT01705288 is a clinical study titled "Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study". Over 600,000 hysterectomies are performed annually in the United States. Despite increasing use of less invasive approaches, the majority of hysterectomies are still performed via traditional laparotomy, which can be associated with generally slower recovery and longer lengths of post-operative hosp...
What is the current status of trial NCT01705288?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 103 participants. The study started on 2013-01-01. Estimated completion is 2016-08-24.
What interventions are being tested in trial NCT01705288?
The interventions under investigation include: Laparotomy (PROCEDURE), intravenous narcotics (DRUG), standard anesthesia (DRUG), regional anesthesia (DRUG), Non-steroidal anti-inflammatory drugs (DRUG).
Who is sponsoring clinical trial NCT01705288?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01705288's enrollment target sits among peer trials
103 180th of 2000 higher than 1,821 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI